HER2-positive breast cancer – Available anti-HER2 therapies and new agents under investigation
Introduction and objectives Breast cancer (BC) is the most common malignancy and the leading cause of cancer death among women. About 15–20% of all BCs are HER2-positive. Proper assessment of HER2 status is crucial to choose appropriate treatment. The review summarizes data on anti-HER2 drugs used t...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Institute of Rural Health
2020-06-01
|
| Series: | Journal of Pre-Clinical and Clinical Research |
| Subjects: | |
| Online Access: | http://www.journalssystem.com/jpccr/HER2-positive-breast-cancer-Available-anti-HER2-therapies-and-new-agents-under-investigation,122068,0,2.html |